Oxford Cannabinoid Technologies Holdings (FRA:0CB) Net Income (Continuing Operations) : €-4.85 Mil (TTM As of Oct. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Oxford Cannabinoid Technologies Holdings's Net Income (Continuing Operations) for the six months ended in Oct. 2023 was €-2.31 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Oct. 2023 was €-4.85 Mil.

Oxford Cannabinoid Technologies Holdings Net Income (Continuing Operations) Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Net Income (Continuing Operations) Chart

Oxford Cannabinoid Technologies Holdings Annual Data

Trend

May18

May19

May20

May21

Apr23

Net Income (Continuing Operations)

-3.01

-2.40

-3.74

-6.75

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
	May19	Nov19	May20	Nov20	May21	Nov21	Oct22	Apr23	Oct23
Net Income (Continuing Operations)	Get a 7-Day Free Trial				-2.83	-2.40	-4.27	-2.54	-2.31

Oxford Cannabinoid Technologies Holdings Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Oct. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-4.85 Mil.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Oxford Cannabinoid Technologies Holdings Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (FRA:0CB) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

OCTP:UK

Address

267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT

Website

https://www.oxcantech.com

Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Headlines

No Headlines